Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by Feedity)
Updated: 2 hours 40 min ago

Merck Takes 3 Major Shots at COVID-19: Themis, IAVI and Ridgeback Bio

Tue, 05/26/2020 - 02:00
Merck has largely stayed out of the COVID-19 battle, but exploded into it with three major deals and collaborations today.

CEPI-Backed Novavax Doses First Patients with COVID-19 Vaccine Candidate

Tue, 05/26/2020 - 02:00
The Maryland-based company has enrolled and dosed its first patients in a Phase I/II study.

Biopharma Update on the Novel Coronavirus: May 26

Tue, 05/26/2020 - 02:00
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 26, 2020.

WHO Pauses Hydroxychloroquine Arm of COVID-19 Study Following Safety Concerns

Tue, 05/26/2020 - 02:00
Questions over the efficacy and safety of hydroxychloroquine continue to be raised following the World Health Organization’s decision to temporarily halt a study of the malaria drug as a potential treatment for COVID-19.

FDA Action Alert: Evofem, Sanofi, Regeneron and Incyte

Tue, 05/26/2020 - 02:00
Heading into the first week after Memorial Day, which in the U.S. marks the typical beginning of summer, the U.S. Food and Drug Administration has a number of drug approvals on the calendar. Here’s a look.

Sanofi and Regeneron's Dupixent Scores Another Approval for Dermatitis, This Time in Kids

Tue, 05/26/2020 - 02:00
To date, Dupixent is the only biologic approved for this age group.

Clinical Catch-Up: May 18-22

Tue, 05/26/2020 - 02:00
Non-COVID-19 clinical trial updates are outweighing COVID-19 studies, particularly with the American Society of Clinical Oncology meeting coming up soon. Here’s a look.

Biotech Bay Companies Fighting Against COVID-19

Tue, 05/26/2020 - 02:00
Biotech Bay, the bustling biotech industry around San Francisco in California, is home to many biopharma companies developing diagnostics, therapies, and vaccines to fight against coronavirus disease 2019 (COVID-19) and the virus that causes it, called SARS-CoV-2.

With New Strategic Focus, Sanofi Sells Off Regeneron Investments to Finance the Future

Tue, 05/26/2020 - 02:00
Sanofi is selling off its nearly $13 billion in investments in longtime development partner Regeneron as the France-based company shifts its strategy to focus on indications such as oncology, neurology, rare diseases and hematology.

Insitro Eyes Technology Expansion with $143M Series B Funding Round

Tue, 05/26/2020 - 02:00
The funding will be used to continue to build the company’s technology and automation, which enable data generation at a larger scale. This will expand Insitro’s ability to create predictive models of human disease.

Argenx’s Myasthenia Gravis Drug Shows Positive Results in Late-Stage Trial

Tue, 05/26/2020 - 02:00
MG is a rare and chronic autoimmune disease marked by IgG antibodies disrupting communication between nerves and muscles.

FDA Grants Priority Review to Alnylam’s RNAi Therapy for Primary Hyperoxaluria Type 1

Tue, 05/26/2020 - 02:00
Alnylam Pharmaceuticals’ lumasiran for a chronic kidney stone disease was granted Priority Review status by the U.S. Food and Drug Administration. It will have a target action date of December 3, 2020.

FDA Gives Thumbs-Up to Sunovion's Under-the-Tongue Parkinson's Drug

Fri, 05/22/2020 - 02:00
“Today’s approval of Kynmobi advances treatment options for people with Parkinson’s disease who experience OFF episodes and the associated disruption of everyday activities,” said Antony Loebel, Sunovion’s president and chief executive officer.

Sorrento Responds to Criticism of COVID-19 Neutralizing Antibodies

Fri, 05/22/2020 - 02:00
Henry Li, Sorrento's co-founder, director, president and chief executive officer, did a follow-up interview with BioSpace to discuss the news and speculation surrounding it.

CanSino Publishes Phase I Data for COVID-19 Vaccine Candidate, Moves into Phase II

Fri, 05/22/2020 - 02:00
A COVID-19 vaccine candidate under development by China’s CanSino Biologics is moving forward in development after the company published data supporting its safety in patients.

Biopharma Update on the Novel Coronavirus: May 22

Fri, 05/22/2020 - 02:00
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.

Roche Acquires Stratos Genomics to Expand Nanopore Sequencing Technology

Fri, 05/22/2020 - 02:00
Roche hopes to advance the development of its own nanopore sequencer, which would use a new approach combining electronic and biological components to sequence DNA quickly and at low cost.

Research Roundup: Emerging Viral Diseases and More

Fri, 05/22/2020 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

BioSpace Movers & Shakers, May 22

Fri, 05/22/2020 - 02:00
Pharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers.

Mammoth’s GSK Collaboration Aims to End Dichotomy Between Lab and Home Dx Tests, CEO Says

Fri, 05/22/2020 - 02:00
The collaboration, announced Wednesday, aims to make disposable, hand-held diagnostics that are as accurate as lab tests and as easy to use as home pregnancy kits.